Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts
Phase 1 interim results expected for SPY002, two distinct extended half-life TL1A antibodies, in 2Q2025 Phase 1 interim results expected...
Phase 1 interim results expected for SPY002, two distinct extended half-life TL1A antibodies, in 2Q2025 Phase 1 interim results expected...
TEL AVIV, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors...
-Reports Third Consecutive Quarter of Revenue above $5 million -First Nine Months Revenue Growth of 3% YOY - Backlog Remains...
Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth...
Burlington, Ontario--(Newsfile Corp. - January 13, 2025) - Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company')...
Delivers Positive Fourth Quarter Comparable Restaurant Revenue Growth ENGLEWOOD, Colo., Jan. 13, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc....
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25 Deepening responses observed over time...
– Unaudited 2024 total revenue of approximately $814 million, exceeding guidance – – Four approval applications submitted to FDA in...
SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a developer of artificial intelligence software for robotic...
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or...
Creates the second largest publicly traded BDC by total assets NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Blue Owl Capital...
Cash, Cash Equivalents and Short-Term Investments Increased Approximately $15.5 million in the Fourth Quarter of 2024 REDWOOD CITY, Calif., Jan. 13,...
SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- J.P. Morgan Healthcare Conference -- NVIDIA today announced new partnerships to transform the $10...
CARMEL, Ind., Jan. 13, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Acquisition immediately adds one of the highest technology readiness level advanced nuclear reactors in development and significantly expands NANO Nuclear’s...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:NRXP) are discussed in this article. NRX Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage...
Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Lucid...
Sheridan, Wyoming--(Newsfile Corp. - January 13, 2025) - LSEB Creative Corp. (OTCQB: LSEB) (the "Company"), a visionary new entrant in...
Acquisition immediately adds one of the highest technology readiness level advanced nuclear reactors in development and significantly expands NANO Nuclear’s...
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), today...
Riyadh, Saudi Arabia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company specializing...
Riyadh, Saudi Arabia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company specializing...
WISeKey’s Subsidiary, WISeSat.Space to Launch a New-Generation Satellite on January 14, a Significant Milestone in the Creation of a Global...
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced...
SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics...
Company to Accelerate Recovery and Monetization of Rare Earth Metals Transaction Prohibits Short Selling, Optimizes Capital Structure, and Aligns Investors...
LAS VEGAS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC: GLXZ), the world’s largest independent developer and distributor...
White Label Partnership Enters its 2nd Year SCHAUMBURG, IL, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the...
HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation...
CHICAGO, January 13, 2025 /PRNewswire/ -- First Industrial Realty Trust, Inc. (NYSE: FR), a leading fully integrated owner, operator and developer...
VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the...
-- Initiated dosing in Phase 1 clinical trial cohort evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in...
This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and procurement of Ebanga™, with a...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:RRGB) are discussed in this article. Red Robin Gourmet Burgers Inc. has exhibited...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:LAB) are discussed in this article. Standard BioTools Inc. (NASDAQ: LAB) experienced a...
PDUFA Target Action Date for Aficamten Set for September 26, 2025;Commercial Launch Preparations Underway for First Potential Approval Five-Year Aspirations Outline...
Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to be...
Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restricted...
• Plan to report top-line results from registration-directed SUMMIT trial in NonAdvSM patients in July 2025 • Plan to report...